These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16816034)

  • 61. A physician charter: the 10th anniversary.
    Cassel CK; Hood V; Bauer W
    Ann Intern Med; 2012 Aug; 157(4):290-1. PubMed ID: 22910940
    [No Abstract]   [Full Text] [Related]  

  • 62. Allocating health care morally.
    Elhauge E
    Calif Law Rev; 1994 Dec; 82(6):1449-544. PubMed ID: 11660282
    [No Abstract]   [Full Text] [Related]  

  • 63. Getting their say, or getting their way? Has participation strengthened the patient "voice" in the National Institute for Clinical Excellence?
    Quennell P
    J Manag Med; 2001; 15(3):202-19. PubMed ID: 11547580
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The NHS and market forces in healthcare: the need for organisational ethics.
    Frith L
    J Med Ethics; 2013 Jan; 39(1):17-21. PubMed ID: 23087185
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ethical issues regarding the delivery of health-care services.
    Rescher N
    Conn Med; 1977 Aug; 41(8):501-6. PubMed ID: 891188
    [No Abstract]   [Full Text] [Related]  

  • 66. [Ethical basis of priority setting in healthcare].
    Marckmann G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):867-73. PubMed ID: 20853082
    [TBL] [Abstract][Full Text] [Related]  

  • 67. It is the lifetime that matters: public preferences over maximising health and reducing inequalities in health.
    Dolan P; Tsuchiya A
    J Med Ethics; 2012 Sep; 38(9):571-3. PubMed ID: 22493185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Searching for cost effectiveness thresholds in the NHS.
    Appleby J; Devlin N; Parkin D; Buxton M; Chalkidou K
    Health Policy; 2009 Aug; 91(3):239-45. PubMed ID: 19168255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Should there be separate psychiatric services for ethnic minority groups?
    Bhui K; Sashidharan SP
    Br J Psychiatry; 2003 Jan; 182():10-2. PubMed ID: 12509312
    [No Abstract]   [Full Text] [Related]  

  • 70. The fall and rise of the NHS.
    Abbasi K
    J R Soc Med; 2017 Oct; 110(10):387. PubMed ID: 29043900
    [No Abstract]   [Full Text] [Related]  

  • 71. Comment on 'a capacity-based approach for addressing ancillary-care needs: implications for research in resource limited settings'.
    Richardson HS
    J Med Ethics; 2012 Nov; 38(11):677-8. PubMed ID: 22518047
    [No Abstract]   [Full Text] [Related]  

  • 72. Tisagenlecleucel for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukaemia in People Aged up to 25 Years: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
    Walton M; Sharif S; Simmonds M; Claxton L; Hodgson R
    Pharmacoeconomics; 2019 Oct; 37(10):1209-1217. PubMed ID: 30982165
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Preventive ethics and rural healthcare: addressing issues on a systems level.
    Vernillo A
    Am J Bioeth; 2008 Apr; 8(4):61-2; author reply W3-4. PubMed ID: 18576262
    [No Abstract]   [Full Text] [Related]  

  • 74. Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis.
    Mujica-Mota R; Varley-Campbell J; Tikhonova I; Cooper C; Griffin E; Haasova M; Peters J; Lucherini S; Talens-Bou J; Long L; Sherriff D; Napier M; Ramage J; Hoyle M
    Health Technol Assess; 2018 Sep; 22(49):1-326. PubMed ID: 30209002
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ethics and high-value care.
    DeCamp M; Tilburt JC
    J Med Ethics; 2017 May; 43(5):307-309. PubMed ID: 28130386
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modifying NICE's Approach to Equity Weighting.
    Paulden M; McCabe C
    Pharmacoeconomics; 2021 Feb; 39(2):147-160. PubMed ID: 33517512
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The cancer technology appraisal programme of the UK's National Institute for Clinical Excellence.
    Littlejohns P; Barnett D; Longson C;
    Lancet Oncol; 2003 Apr; 4(4):242-50. PubMed ID: 12681268
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cost effectiveness and the role of the National Institute of Health and Care Excellence (NICE) in interventional radiology.
    Maudgil DD
    Clin Radiol; 2021 Mar; 76(3):185-192. PubMed ID: 33081990
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extortion and the ethics of "Topping Up".
    Sachs B
    Camb Q Healthc Ethics; 2009; 18(4):443-5. PubMed ID: 19739335
    [No Abstract]   [Full Text] [Related]  

  • 80. The National Institute for Health and Clinical Excellence (NICE) and drug treatment for Alzheimer's disease.
    Iliffe S
    CNS Drugs; 2007; 21(3):177-84. PubMed ID: 17338591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.